The Study of INTRA Spine Non Fusion Technique in the Treatment of Lumbar Degenerative Disease
Launched by QIANFOSHAN HOSPITAL · Oct 4, 2023
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Retrospective analysis of patients admitted to the Department of Orthopedic and Spinal Surgery of our hospital who underwent the INTRA Spine dynamic stabilization system and lumbar fusion technology for the treatment of lumbar degenerative diseases. General, clinical, and imaging data were collected before and 7 days, 6 months, and 12 months after surgery. The general information of the patient includes gender, age, course of disease, conservative treatment time, surgical time, nail/implant placement time, bleeding volume, and length of hospital stay; The clinical treatment effect was evalu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient's clinical manifestations, physical examination, and imaging data all support the diagnosis of degenerative lumbar spondylosis
- • Those who have undergone strict and formal conservative treatment for at least 3 months before surgery and have no significant improvement in symptoms
- • Preoperative imaging examination showed single responsible segment protrusion or protrusion leading to segment stenosis
- • Surgeries are performed by the same chief surgeon.
- Exclusion Criteria:
- • Lumbar instability, lumbar spondylolisthesis above grade II
- • Patients with severe osteoporosis, tuberculosis, or tumors
- • Systemic diseases that affect surgical treatment and medication, such as heart disease, liver disease, and kidney disease
- • Patients with mental illness, poor compliance, and inability to cooperate in completing follow-up
About Qianfoshan Hospital
Qianfoshan Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. Located in Shandong Province, China, the hospital is renowned for its commitment to excellence in patient care and medical education. With a multidisciplinary team of experienced professionals, Qianfoshan Hospital focuses on a wide range of therapeutic areas, striving to enhance treatment options and improve patient outcomes. The institution actively collaborates with various stakeholders to ensure the highest standards of ethics and efficacy in its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
Jinan, Shandong, China
Patients applied
Trial Officials
Hao-Xuan Zhang, Ph.D/MD
Study Chair
Shandong First Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported